Elloria Medical Technologies

Company Overview

Snapshot

Founded in January 2010 by Arnon Epstein, Elloria Medical Technologies operates with 1–10 employees. The company has raised $1.2 million across one funding round. In October 2013, Elloria Medical Technologies secured a grant from the Office of the Chief Scientist.

Business overview

Elloria Medical Technologies develops aesthetic and medical applications and devices within the Health Tech & Life Sciences sector. Its core product, Electro Chemical Hair Obliteration (ECHO), is a permanent hair-removal system utilizing patented Ellorion technology. This technology combines the effectiveness of electrology with the ease and speed of light-based systems, serving both B2B and B2C markets in dermatology and non-invasive medical technologies.

Company Intelligence Q&A

What is Elloria Medical Technologies' primary product?

Elloria Medical Technologies' primary product is Electro Chemical Hair Obliteration (ECHO), a permanent hair-removal system based on its patented Ellorion technology.

When was Elloria Medical Technologies founded?

Elloria Medical Technologies was founded in January 2010.

Who is the founder of Elloria Medical Technologies?

Arnon Epstein is the Co-Founder & CEO of Elloria Medical Technologies.

What type of technology does ECHO utilize for hair removal?

ECHO utilizes Ellorion technology, which combines the efficacy of electrology with the ease-of-use and speed of light-based hair-removal systems by delivering negatively charged ions through the hair shaft to destroy the hair papilla.

What was a notable early funding event for Elloria Medical Technologies?

In October 2013, Elloria Medical Technologies secured a grant from the Office of the Chief Scientist.